Johnson & Johnson Shares Outstanding 2006-2018 | JNJ

Current and historical number of shares outstanding for Johnson & Johnson (JNJ) from 2006 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Johnson & Johnson Annual Shares Outstanding
(Millions of US $)
2017 $2,745
2016 $2,789
2015 $2,813
2014 $2,864
2013 $2,877
2012 $2,813
2011 $2,775
2010 $2,789
2009 $2,789
2008 $2,836
2007 $2,911
2006 $2,961
2005 $3,003
Johnson & Johnson Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $2,721
Q1 2018 $2,732
Q4 2017 $2,745
Q3 2017 $2,738
Q2 2017 $2,742
Q1 2017 $2,755
Q4 2016 $2,789
Q3 2016 $2,785
Q2 2016 $2,794
Q1 2016 $2,804
Q4 2015 $2,813
Q3 2015 $2,807
Q2 2015 $2,812
Q1 2015 $2,826
Q4 2014 $2,864
Q3 2014 $2,864
Q2 2014 $2,874
Q1 2014 $2,875
Q4 2013 $2,877
Q3 2013 $2,881
Q2 2013 $2,893
Q1 2013 $2,859
Q4 2012 $2,813
Q3 2012 $2,818
Q2 2012 $2,798
Q1 2012 $2,775
Q4 2011 $2,775
Q3 2011 $2,778
Q2 2011 $2,781
Q1 2011 $2,773
Q4 2010 $2,789
Q3 2010 $2,786
Q2 2010 $2,796
Q1 2010 $2,797
Q4 2009 $2,789
Q3 2009 $2,793
Q2 2009 $2,782
Q1 2009 $2,790
Q4 2008 $2,836
Q3 2008 $2,831
Q2 2008 $2,845
Q1 2008 $2,866
Q4 2007 $2,911
Q3 2007 $2,913
Q2 2007 $2,923
Q1 2007 $2,924
Q4 2006 $2,961
Q3 2006 $2,948
Q2 2006 $2,974
Q1 2006 $2,993
Q4 2005 $3,003
Q3 2005 $3,006
Q2 2005 $3,025
Q1 2005 $3,024
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $347.436B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $242.341B 14.19
Novartis AG (NVS) Switzerland $190.356B 16.33
Merck (MRK) United States $179.189B 15.82
AbbVie (ABBV) United States $145.249B 14.19
Novo Nordisk (NVO) Denmark $118.145B 18.89
Eli Lilly (LLY) United States $110.019B 20.37
Sanofi (SNY) France $103.584B 13.11
AstraZeneca (AZN) United Kingdom $98.732B 10.86
GlaxoSmithKline (GSK) United Kingdom $98.701B 13.18
Bristol-Myers Squibb (BMY) United States $98.007B 17.74